Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lupus erythematosus, systemic
Symptom C0040053|thrombosis
Sentences 13
PubMedID- 22707612 Genetic risk factors for thrombosis in systemic lupus erythematosus.
PubMedID- 23504607 thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis.
PubMedID- 23676348 Introduction: predicting thrombosis in patients with systemic lupus erythematosus (sle) and/or antiphospholipid antibodies (apl) is still challenging.
PubMedID- 21243310 Libman-sacks endocarditis, antiphospholipid antibodies and arterial thrombosis in systemic lupus erythematosus: case report.
PubMedID- 25832953 Cerebral venous thrombosis as a complication of neuropsychiatric systemic lupus erythematosus.
PubMedID- 22193216 Reevaluation of predictive value of acl and anti-beta2gp1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world.
PubMedID- 22859353 Hydroxychloroquine (hcq) has been shown in retrospective studies to decrease apl titers in laboratory studies, and to decrease thrombosis risk in patients with systemic lupus erythematosus (sle).
PubMedID- 22900201 thrombosis in systemic lupus erythematosus: a review article.
PubMedID- 25117655 We investigated the relationship between tpo and the occurrence of thrombocytopenia and thrombosis in patients with systemic lupus erythematosus (sle).
PubMedID- 26090493 Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in china.
PubMedID- 26201124 Mechanisms of thrombosis in systemic lupus erythematosus.
PubMedID- 26364556 The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: a general population-based study.
PubMedID- 26075289 In particular, apl positivity has been identified as one of the main determinants of thrombosis among subjects with systemic lupus erythematosus (sle) .

Page: 1